Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology|April 18, 2021
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemiaLiza Konnikova, Tanya O Robinson, Anna H Owings, et al.
The Journal of Allergy and Clinical Immunology|March 9, 2024
A randomized double-blinded trial to assess recurrence of systemic allergic reactions following COVID-19 mRNA vaccinationMuhammad B Khalid, Ellen Zektser, Eric Chu, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2022
Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative GroupGregor Hoermann, Karl Sotlar, Mohamad Jawhar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative GroupKarl Sotlar, Tracy I George, Philip Kluin, et al.
The Journal of Allergy and Clinical Immunology|March 22, 2021
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator ConferenceJason Gotlib, Tracy I George, Melody C Carter, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM ConsortiumPolina Pyatilova, Cem Akin, Iván Alvarez-Twose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαTPeter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM ConsortiumPeter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 20, 2022
Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic MastocytosisJason Gotlib, Juliana Schwaab, William Shomali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 24, 2021
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical ReviewTheo Gülen, Cem Akin, Patrizia Bonadonna, et al.
Pageof 9